|
1
|
Scheffner M, Munger K, Byrne JC and Howley
PM: The state of the p53 and retinoblastoma genes in human cervical
carcinoma cell lines. Proc Natl Acad Sci USA. 88:5523–5527. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beevi SS, Rasheed MH and Geetha A:
Evidence of oxidative and nitrosative stress in patients with
cervical squamous cell carcinoma. Clin Chim Acta. 375:119–123.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cotran RS, Kumar V and Robbins SL: Robbins
Pathologic Basis of Disease. 5th edition. W.B. Saunders Company;
Philadelphia: 1994
|
|
4
|
Ding B, Chi SG, Kim SH, et al: Role of p53
in antioxidant defense of HPV-positive cervical carcinoma cells
following H2O2 exposure. J Cell Sci.
120:2284–2294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh M, Sharma H and Singh N: Hydrogen
peroxide induces apoptosis in HeLa cells through mitochondrial
pathway. Mitochondrion. 7:367–373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Srinivas P, Gopinath G, Banerji A, Dinakar
A and Srinivas G: Plumbagin induces reactive oxygen species, which
mediate apoptosis in human cervical cancer cells. Mol Carcinog.
40:201–211. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alexandre J, Batteux F, Nicco C, et al:
Accumulation of hydrogen peroxide is an early and crucial step for
paclitaxel-induced cancer cell death both in vitro and in vivo. Int
J Cancer. 119:41–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang TS, Cho CS, Park S, Yu S, Kang SW
and Rhee SG: Peroxiredoxin III, a mitochondrion-specific
peroxidase, regulates apoptotic signaling by mitochondria. J Biol
Chem. 279:41975–41984. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Shoji W, Takano H, et al: Increased
susceptibility of MER5 (peroxiredoxin III) knockout mice to
LPS-induced oxidative stress. Biochem Biophys Res Commun.
355:715–721. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Shoji W, Oshima H, Obinata M,
Fukumoto M and Kanno N: Crucial role of peroxiredoxin III in
placental antioxidant defense of mice. FEBS Lett. 582:2431–2434.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim K, Yu M, Han S, et al: Expression of
human peroxiredoxin isoforms in response to cervical
carcinogenesis. Oncol Rep. 21:1391–1396. 2009.PubMed/NCBI
|
|
12
|
Riethdorf S, Riethdorf L, Schulz G, et al:
Relationship between telomerase activation and HPV 16/18 oncogene
expression in squamous intraepithelial lesions and squamous cell
carcinomas of the uterine cervix. Int J Gynecol Pathol. 20:177–185.
2001. View Article : Google Scholar
|
|
13
|
Couturier J, Sastre-Garau X,
Schneider-Maunoury S, Labib A and Orth G: Integration of
papillomavirus DNA near myc genes in genital carcinomas and its
consequences for proto-oncogene expression. J Virol. 65:4534–4538.
1991.PubMed/NCBI
|
|
14
|
Subramanyam D and Krishna S: c-Myc
substitutes for Notch1-CBF1 functions in cooperative transformation
with papillomavirus oncogenes. Virology. 347:191–198. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wonsey DR, Zeller KI and Dang CV: The
c-Myc target gene PRDX3 is required for mitochondrial homeostasis
and neoplastic transformation. Proc Natl Acad Sci USA.
99:6649–6654. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mimica M, Tomić S, Kardum G, Hofman ID,
Kaliterna V and Pejković L: Ki-67 quantitative evaluation as a
marker of cervical intraepithelial neoplasia and human
papillomavirus infection. Int J Gynecol Cancer. 20:116–119. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanprasertpong J, Tungsinmunkong K,
Chichareon S, et al: Correlation of p53 and Ki-67 (MIB-1)
expressions with clinicopathological features and prognosis of
early stage cervical squamous cell carcinomas. J Obstet Gynaecol
Res. 36:572–580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nonn L, Berggren M and Powis G: Increased
expression of mitochondrial peroxiredoxin-3 (thioredoxin
peroxidase-2) protects cancer cells against hypoxia and
drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res.
1:682–689. 2003.
|
